Fundraising Fox
/Companies
Sign in

Synthio Labs

YC X25

San Francisco, US · Founded 2024 · 29 employees · Hiring · 7 known investors

Find your way into Synthio Labs

Sign up to see every warm intro you have to Synthio Labs

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Synthio Labs team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Synthio Labs develops AI-powered synthesis and clinical interpretation systems for pharmaceutical interactions, offering text, voice, and video interfaces designed for healthcare professionals and patients that integrate FDA labels, drug mechanisms, and clinical literature.

Also known as SynthioLabs, Ltd. · SynthioLabs

AI & Machine LearningBiotechDigital HealthHealthtechArtificial IntelligenceHealthcareEnterpriseUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (X25)

Synthio Labs was founded in 2024 by Supreet Deshpande, Sahitya Sridhar, and Rajashekar Vasantha.

SDSupreet Deshpande
Supreet DeshpandeCo-Founder and CEOSupreet Deshpande has over a decade of experience in AI and machine learning applied to life sciences, including prior roles at McKinsey and ZS where he led AI initiatives for pharmaceutical and biotech clients across clinical development, medical affairs, and commercial functions.
SSSahitya Sridhar
Sahitya SridharCo-Founder (Product, Growth)Sahitya Sridhar previously worked at Audible on AI systems for content personalization and text-to-speech technology, as well as developer efficiency initiatives. She is now building AI agents for life sciences applications at Synthio Labs.
RVRajashekar Vasantha
Rajashekar VasanthaCo-FounderRajashekar Vasantha conducted AI research at AWS and studied at NYU Center for Data Science before founding Synthio Labs, where he develops AI agents for life sciences applications.
RV
Rajashekhar VasanthaFounder
SD
Supreet Deshpande Sahitya SridharFounder
JN
Jarvis Nguyens Office Associate
LD
Leanne DsouzaExecutive Assistant

Investors · 7

Peak XV Partnerslisted by Peak XV PartnersBengaluru · $100K – $10M

How we know: funding news · Y Combinator's founder network · Not right? Tell us

Pioneerlisted by PioneerToronto, Ontario

How we know: Y Combinator's founder network · pioneerfund.vc · open dataset · 5k.vc investor directory · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

1984 Ventures Management, LlcreportedSan Francisco · $750K – $1M

How we know: funding news · Y Combinator's founder network · Not right? Tell us

Catalio Capital Management, LPreportedNew York

How we know: Y Combinator's founder network · Not right? Tell us

Llama venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Funding

SEC filings, press & company announcements

$5M disclosed across 1 of 2 rounds · 2025

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 5

ConvexiaConvexia provides AI-powered drug discovery and evaluation software that scans global sources for overlooked drug assets and runs deep in silico simulations across 50+ models to assess binding, toxicity, pharmacokinetics, and immunogenicity. The platform combines AI agents with expert human review to accelerate drug asset evaluation for biotech companies, pharma firms, and venture investors.
Multiply LabsMultiply Labs builds robotic systems that automate biologics manufacturing for pharmaceutical companies. The platform orchestrates existing laboratory instruments in a closed, sterile environment to increase throughput by up to 100x while reducing costs and contamination risk.
AbiologicsAbiologics uses computational design tools to create protein-inspired molecules called Synteins, engineered to avoid the vulnerabilities of natural protein medicines while retaining biological function. The company develops these molecules as a new class of therapeutics with the aim of advancing candidates toward clinical development.
TheoraTheora partners with Indian healthcare organizations to aggregate, structure, and de-identify clinical and genomic data for pharmaceutical and AI research, addressing the underrepresentation of Indian populations in drug discovery and genetic studies.
Maven BioMaven Bio provides software for biotech investment firms to accelerate due diligence and thesis development, automating screening, competitive analysis, and clinical data review to compress research timelines from days to hours.

Companies working in the same space as Synthio Labs.

Legal entities · 1

corporate structure
SynthioLabs, Ltd.

In the news

Synthio Labs Raises $5M in Fundingfinsmes.com · Nov 2025SynthioLabs: World's First AI Medical Expert for Pharma GTM Teamsycombinator.com · May 2025

Frequently asked questions

What does Synthio Labs do?
Synthio Labs develops AI-powered synthesis and clinical interpretation systems for pharmaceutical interactions, offering text, voice, and video interfaces designed for healthcare professionals and patients that integrate FDA labels, drug mechanisms, and clinical literature.
Who founded Synthio Labs?
Synthio Labs was founded by Supreet Deshpande, Sahitya Sridhar, Rajashekar Vasantha in 2024.
Who are Synthio Labs's investors?
Synthio Labs's investors include Elevation Capital, Peak XV Partners, Pioneer, Y Combinator, 1984 Ventures Management, Llc, Catalio Capital Management, LP, Llama ventures.
How much funding has Synthio Labs raised?
Synthio Labs has disclosed $5M raised across 1 of its 2 known rounds.
Where is Synthio Labs headquartered?
Synthio Labs is headquartered in San Francisco, US.